The first ‘Trends in Cell-Based Assays’ forum was held this week in Cambridge, hosted by ATCC and BioAgilytix, who partnered with Shire Pharmaceuticals, Takeda Pharmaceuticals, Visterra and the former senior advisor of Science Innovation and Policy for the FDA.

Click for full article